Drug Type Small molecule drug |
Synonyms |
Target |
Action stimulants |
Mechanism PKM2 stimulants(Pyruvate kinase isozymes M1/M2 stimulants) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dermatitis, Atopic | Preclinical | United Kingdom | 13 Aug 2024 |